Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Dupilumab effectively treated severe alopecia areata in a child.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Abrocitinib may effectively treat stubborn alopecia universalis.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Leflunomide is more likely to help treat alopecia areata than cause it.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Denosumab may cause alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Upadacitinib may cause hair loss.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.